{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:20:13Z","timestamp":1778887213489,"version":"3.51.4"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Given its widespread availability, paracetamol (acetaminophen and p-aminophenol) is frequently ingested in overdose, making paracetamol poisoning one of the most common drug-induced poisonings worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive overview of recent developments in the treatment of acute paracetamol poisoning is presented, with the aim of improving clinicians' understanding of the diagnosis and treatment of patients with paracetamol poisoning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Paracetamol's pharmacokinetics and toxicokinetics are examined, along with its toxicity (doses and early concentrations); massive overdose or high-risk ingestion; treatment of specific populations such as children, pregnant women, and patients with obesity; prognostic markers of paracetamol toxicity; gastrointestinal decontamination; renal replacement therapy; antidotal therapy with acetylcysteine dosing regimens; adverse reactions; and acetylcysteine alternatives or adjunctive therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although paracetamol poisoning seems straightforward in terms of risk assessment and treatment, the developments in its diagnosis and treatment reveal that this field is constantly evolving. Multiple factors must be considered in patients with paracetamol poisoning, making its treatment challenging. This comprehensive overview aims to address these challenges.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001403","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:00:48Z","timestamp":1762196448000},"page":"220-228","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Acute Paracetamol Overdose: A Comprehensive Overview"],"prefix":"10.1097","volume":"48","author":[{"given":"Arjen","family":"Koppen","sequence":"first","affiliation":[{"name":"Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Mian","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"},{"name":"University of Groningen, University Medical Center Groningen, Department of Pediatrics, Beatrix Children's Hospital, Groningen, the Netherlands; and"},{"name":"Pharmacometrics Expertise Center of the Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-0591","authenticated-orcid":false,"given":"Marieke G. G.","family":"Sturkenboom","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"},{"name":"Pharmacometrics Expertise Center of the Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"R1-20260313","first-page":"CD003328","article-title":"Interventions for paracetamol (acetaminophen) overdose","volume":"2","author":"Chiew","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20260313","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17425255.2023.2223959","article-title":"Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease","volume":"19","author":"Chidiac","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R3-20260313","doi-asserted-by":"crossref","first-page":"116056","DOI":"10.1016\/j.bcp.2024.116056","article-title":"Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure","volume":"228","author":"Ramachandran","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"R4-20260313","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/15563650.2025.2479721","article-title":"Paracetamol (acetaminophen) poisoning; consensus definitions of poisoning types and outcomes to be used in the clinical toxicology recommendations collaborative systematic review","volume":"63","author":"Chiew","year":"2025","journal-title":"Clin Toxicol (Phila)"},{"key":"R5-20260313","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/15563650.2017.1334915","article-title":"Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2)","volume":"55","author":"Chiew","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"key":"R6-20260313","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/papr.12130","article-title":"Acetaminophen (paracetamol) oral absorption and clinical influences","volume":"14","author":"Raffa","year":"2014","journal-title":"Pain Pract"},{"key":"R7-20260313","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/15563650.2016.1247959","article-title":"Can a serum acetaminophen concentration obtained less than 4 hours post-ingestion determine which patients do not require treatment with acetylcysteine?","volume":"55","author":"Yarema","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"key":"R8-20260313","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-198207020-00001","article-title":"Clinical pharmacokinetics of paracetamol","volume":"7","author":"Forrest","year":"1982","journal-title":"Clin Pharmacokinet"},{"key":"R9-20260313","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/mcp.2002.121857","article-title":"The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage","volume":"71","author":"Schi\u00f8dt","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R10-20260313","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","article-title":"Acetaminophen hepatotoxicity: Paradigm for understanding mechanisms of drug-induced liver injury","volume":"19","author":"Jaeschke","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"R11-20260313","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/17425255.2023.2259787","article-title":"Advances in the understanding of acetaminophen toxicity mechanisms: a clinical toxicology perspective","volume":"19","author":"Chiew","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R12-20260313","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"R13-20260313","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","article-title":"PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"R14-20260313","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1081\/DMR-200033441","article-title":"The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role","volume":"36","author":"Lieber","year":"2004","journal-title":"Drug Metab Rev"},{"key":"R15-20260313","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","article-title":"Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions","volume":"17","author":"Yan","year":"2018","journal-title":"Redox Biol"},{"key":"R16-20260313","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/1742-6723.12610","article-title":"N-acetylcysteine regimens for paracetamol overdose: time for a change?","volume":"28","author":"Wong","year":"2016","journal-title":"Emerg Med Australas"},{"key":"R17-20260313","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1080\/15563650.2023.2293452","article-title":"Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver","volume":"61","author":"Bateman","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"R18-20260313","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2016.03.003","article-title":"A minireview on N-acetylcysteine: an old drug with new approaches","volume":"151","author":"Elbini Dhouib","year":"2016","journal-title":"Life Sci"},{"key":"R19-20260313","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mpd.2000.107624","article-title":"Why young children are resistant to acetaminophen poisoning","volume":"137","author":"Tenenbein","year":"2000","journal-title":"J Pediatr"},{"key":"R20-20260313","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0022-3476(99)70122-8","article-title":"Predicting concentrations in children presenting with acetaminophen overdose","volume":"135","author":"Anderson","year":"1999","journal-title":"J Pediatr"},{"key":"R21-20260313","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1542\/peds.55.6.871","article-title":"Acetaminophen poisoning and toxicity","volume":"55","author":"Rumack","year":"1975","journal-title":"Pediatrics"},{"key":"R22-20260313","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(71)91125-1","article-title":"Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage","volume":"1","author":"Prescott","year":"1971","journal-title":"Lancet"},{"key":"R23-20260313","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med"},{"issue":"Spec No","key":"R24-20260313","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1981.00340030112020","article-title":"Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment","volume":"141","author":"Rumack","year":"1981","journal-title":"Arch Intern Med"},{"key":"R25-20260313","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00228-017-2356-6","article-title":"Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature","volume":"74","author":"Caparrotta","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"R28-20260313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0313","article-title":"Toxicology in the emergency department: what's new?","volume":"83","author":"Motohashi","year":"2022","journal-title":"Br J Hosp Med (Lond)"},{"key":"R29-20260313","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/15563650.2019.1579914","article-title":"What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose?","volume":"57","author":"Hendrickson","year":"2019","journal-title":"Clin Toxicol (Phila)"},{"key":"R30-20260313","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bcp.15201","article-title":"Large paracetamol overdose-higher dose acetylcysteine is required","volume":"89","author":"Bateman","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R31-20260313","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00007691-200504000-00187","article-title":"Acetylcysteine treatment in massive paracetamol poisoning","volume":"27","author":"Sturkenboom","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R32-20260313","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bcp.15199","article-title":"Large paracetamol overdose\u2014Higher dose NAC is NOT required","volume":"89","author":"Thanacoody","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R33-20260313","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology \u2014 drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"R34-20260313","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/pharmaceutics13081302","article-title":"Modelling tools to characterize acetaminophen pharmacokinetics in the pregnant population","volume":"13","author":"Brookhuis","year":"2021","journal-title":"Pharmaceutics"},{"key":"R35-20260313","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","article-title":"Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters","volume":"14","author":"Smit","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R36-20260313","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archpedi.1984.02140430006003","article-title":"Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases","volume":"138","author":"Rumack","year":"1984","journal-title":"Am J Dis Child"},{"key":"R37-20260313","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/mja2.50428","article-title":"Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand","volume":"212","author":"Chiew","year":"2020","journal-title":"Med J Aust"},{"key":"R38-20260313","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/15563650.2011.568491","article-title":"Intravenous paracetamol\u2014An international perspective of toxicity","volume":"49","author":"Gray","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"R39-20260313","doi-asserted-by":"crossref","first-page":"e2327739","DOI":"10.1001\/jamanetworkopen.2023.27739","article-title":"Management of acetaminophen poisoning in the US and Canada: a consensus statement","volume":"6","author":"Dart","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R40-20260313","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.taap.2019.03.004","article-title":"Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model","volume":"370","author":"Conings","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"R41-20260313","first-page":"247","article-title":"Acute acetaminophen overdose during pregnancy","volume":"74","author":"Riggs","year":"1989","journal-title":"Obstet Gynecol"},{"key":"R42-20260313","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/livers3010003","article-title":"Acetaminophen-induced hepatotoxicity in obesity and nonalcoholic fatty liver disease: a critical review","volume":"3","author":"Begriche","year":"2023","journal-title":"Livers"},{"key":"R43-20260313","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/acem.12222","article-title":"Negative predictive value of acetaminophen concentrations within four hours of ingestion","volume":"20","author":"Froberg","year":"2013","journal-title":"Acad Emerg Med"},{"key":"R44-20260313","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eclinm.2019.04.005","article-title":"Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose","volume":"11","author":"Pettie","year":"2019","journal-title":"EClinicalmedicine"},{"key":"R45-20260313","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/15563650.2017.1355058","article-title":"Accuracy of the paracetamol-aminotransferase product to predict hepatotoxicity in paracetamol overdose treated with a 2-bag acetylcysteine regimen","volume":"56","author":"Wong","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"R46-20260313","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/qjmed\/hct062","article-title":"The predictive value of hospital admission serum alanine transaminase activity in patients treated for paracetamol overdose","volume":"106","author":"Al-Hourani","year":"2013","journal-title":"Q J M"},{"key":"R47-20260313","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00228-008-0580-9","article-title":"Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit","volume":"65","author":"Pakravan","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R48-20260313","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S2468-1253(17)30266-2","article-title":"Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies","volume":"3","author":"Dear","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R49-20260313","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1080\/15563650.2021.1961144","article-title":"Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose","volume":"59","author":"Hoegberg","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R50-20260313","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/15563650.2014.946994","article-title":"Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup","volume":"52","author":"Gosselin","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"R51-20260313","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5811\/westjem.2012.4.6885","article-title":"Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and meta-analysis","volume":"14","author":"Green","year":"2013","journal-title":"West J Emerg Med"},{"key":"R52-20260313","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5811\/WESTJEM.59099","article-title":"Is two better than three? A systematic review of two-bag intravenous N-acetylcysteine regimens for acetaminophen poisoning","volume":"24","author":"Cole","year":"2023","journal-title":"West J Emerg Med"},{"key":"R53-20260313","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bcp.12362","article-title":"Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment","volume":"78","author":"Bateman","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R54-20260313","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2050-6511-14-20","article-title":"Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP)","volume":"14","author":"Thanacoody","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"R55-20260313","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/15563650802245497","article-title":"Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose","volume":"46","author":"Pakravan","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"R56-20260313","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s13181-018-0653-9","article-title":"Anaphylactoid reactions to intravenous N-acetylcysteine during treatment for acetaminophen poisoning","volume":"14","author":"Yarema","year":"2018","journal-title":"J Med Toxicol"},{"key":"R57-20260313","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/15563650.2025.2451642","article-title":"The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review","volume":"63","author":"Nazar","year":"2025","journal-title":"Clin Toxicol (Phila)"},{"key":"R58-20260313","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0140-6736(74)92649-X","article-title":"Successful treatment of severe paracetamol overdosage with cysteamine","volume":"1","author":"Prescott","year":"1974","journal-title":"Lancet"},{"key":"R59-20260313","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/2042098612464265","article-title":"Novel acetylcysteine regimens for treatment of paracetamol overdose","volume":"3","author":"Waring","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"R60-20260313","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/bcp.15596","article-title":"Fomepizole should not be used more liberally in paracetamol overdose","volume":"89","author":"Dear","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R61-20260313","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/15563650.2023.2259085","article-title":"Developing new antidotes for poisons with existing effective treatments: a case study of fomepizole in paracetamol poisoning","volume":"61","author":"Dear","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"R62-20260313","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/livers3040039","article-title":"The evolution of circulating biomarkers for use in acetaminophen\/paracetamol-induced liver injury in humans: a scoping review","volume":"3","author":"McGill","year":"2023","journal-title":"Livers"},{"key":"R63-20260313","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/bcp.16371","article-title":"Establishing reference ranges for circulating biomarkers of drug-induced liver injury in healthy human volunteers","volume":"91","author":"Jorgensen","year":"2025","journal-title":"Br J Clin Pharmacol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:00:23Z","timestamp":1773378023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001403","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}